TY - JOUR
T1 - Healthcare-associated urinary tract infections with onset post hospital discharge
AU - Elman, Miriam R.
AU - Williams, Craig D.
AU - Bearden, David T.
AU - Townes, John M.
AU - Heintzman, John D.
AU - Lapidus, Jodi A.
AU - Kullar, Ravina
AU - Markwardt, Sheila
AU - Trieu, Amanda T.
AU - Vahidi, Arrash A.
AU - Mcgregor, Jessina C.
N1 - Funding Information:
This work was supported by the Agency for Healthcare Research and Quality (grant no. 1 R03 HS020970) to J.C.M. and the Oregon Clinical and Translational Research Institute, which is funded by the National Institutes of Health National Center for Advancing Translational Sciences (grant no. UL1TR000128).
Publisher Copyright:
© 2019 by The Society for Healthcare Epidemiology of America.
PY - 2019/8/1
Y1 - 2019/8/1
N2 - Objective: Current surveillance for healthcare-associated (HA) urinary tract infection (UTI) is focused on catheter-associated infection with hospital onset (HO-CAUTI), yet this surveillance does not represent the full burden of HA-UTI to patients. Our objective was to measure the incidence of potentially HA, community-onset (CO) UTI in a retrospective cohort of hospitalized patients.Design: Retrospective cohort study.Setting: Academic, quaternary care, referral center.Patients: Hospitalized adults at risk for HA-UTI from May 2009 to December 2011 were included.Methods: Patients who did not experience a UTI during the index hospitalization were followed for 30 days post discharge to identify cases of potentially HA-CO UTI.Results: We identified 3,273 patients at risk for potentially HA-CO UTI. The incidence of HA-CO UTI in the 30 days post discharge was 29.8 per 1,000 patients. Independent risk factors of HA-CO UTI included paraplegia or quadriplegia (adjusted odds ratio [aOR], 4.6; 95% confidence interval [CI], 1.2-18.0), indwelling catheter during index hospitalization (aOR, 1.5; 95% CI, 1.0-2.3), prior piperacillin-tazobactam prescription (aOR, 2.3; 95% CI, 1.1-4.5), prior penicillin class prescription (aOR, 1.7; 95% CI, 1.0-2.8), and private insurance (aOR, 0.6; 95% CI, 0.4-0.9).Conclusions: HA-CO UTI may be common within 30 days following hospital discharge. These data suggest that surveillance efforts may need to be expanded to capture the full burden to patients and better inform antibiotic prescribing decisions for patients with a history of hospitalization.
AB - Objective: Current surveillance for healthcare-associated (HA) urinary tract infection (UTI) is focused on catheter-associated infection with hospital onset (HO-CAUTI), yet this surveillance does not represent the full burden of HA-UTI to patients. Our objective was to measure the incidence of potentially HA, community-onset (CO) UTI in a retrospective cohort of hospitalized patients.Design: Retrospective cohort study.Setting: Academic, quaternary care, referral center.Patients: Hospitalized adults at risk for HA-UTI from May 2009 to December 2011 were included.Methods: Patients who did not experience a UTI during the index hospitalization were followed for 30 days post discharge to identify cases of potentially HA-CO UTI.Results: We identified 3,273 patients at risk for potentially HA-CO UTI. The incidence of HA-CO UTI in the 30 days post discharge was 29.8 per 1,000 patients. Independent risk factors of HA-CO UTI included paraplegia or quadriplegia (adjusted odds ratio [aOR], 4.6; 95% confidence interval [CI], 1.2-18.0), indwelling catheter during index hospitalization (aOR, 1.5; 95% CI, 1.0-2.3), prior piperacillin-tazobactam prescription (aOR, 2.3; 95% CI, 1.1-4.5), prior penicillin class prescription (aOR, 1.7; 95% CI, 1.0-2.8), and private insurance (aOR, 0.6; 95% CI, 0.4-0.9).Conclusions: HA-CO UTI may be common within 30 days following hospital discharge. These data suggest that surveillance efforts may need to be expanded to capture the full burden to patients and better inform antibiotic prescribing decisions for patients with a history of hospitalization.
UR - http://www.scopus.com/inward/record.url?scp=85067651015&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85067651015&partnerID=8YFLogxK
U2 - 10.1017/ice.2019.148
DO - 10.1017/ice.2019.148
M3 - Article
C2 - 31217038
AN - SCOPUS:85067651015
VL - 40
SP - 863
EP - 871
JO - Infection Control and Hospital Epidemiology
JF - Infection Control and Hospital Epidemiology
SN - 0899-823X
IS - 8
ER -